Yorktown Management & Research Company’s Novo Nordisk NVO Stock Holding History

Yorktown Management & Research Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,000	Closed	-$259K	–	341
2018 Q3	$259K	Hold	11,000	–	–	0.08%	328
2018 Q2	$254K	Hold	11,000	–	–	0.07%	312
2018 Q1	$271K	Hold	11,000	–	–	0.08%	305
2017 Q4	$295K	Buy	+11,000	New	+$280K	0.09%	294
2016 Q4	–	Sell	-10,000	Closed	-$208K	–	387
2016 Q3	$208K	Hold	10,000	–	–	0.05%	261
2016 Q2	$269K	Hold	10,000	–	–	0.06%	205
2016 Q1	$271K	Hold	10,000	–	–	0.05%	252
2015 Q4	$290K	Hold	10,000	–	–	0.05%	254
2015 Q3	$271K	Hold	10,000	–	–	0.04%	281
2015 Q2	$274K	Hold	10,000	–	–	0.05%	304
2015 Q1	$267K	Hold	10,000	–	–	0.05%	290
2014 Q4	$212K	Hold	10,000	–	–	0.04%	386
2014 Q3	$238K	Hold	10,000	–	–	0.05%	325
2014 Q2	$231K	Hold	10,000	–	–	0.04%	386
2014 Q1	$228K	Buy	+10,000	New	+$213K	0.04%	379

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Yorktown Management & Research Company's NVO Position: Q4 2018 in Review

Yorktown Management & Research Company sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 11,000 shares — an estimated $259K sold.

Yorktown Management & Research Company first reported a position in NVO in Q1 2014 and held it in 15 quarters. The position peaked at $295K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

Yorktown Management & Research Company reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
Yorktown Management & Research Company sold 11,000 Novo Nordisk shares in Q4 2018, an estimated $259K.
Yorktown Management & Research Company first reported a position in Novo Nordisk in Q1 2014 and held it in 15 quarters.
Yorktown Management & Research Company's Novo Nordisk position peaked at $295K in Q4 2017.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Yorktown Management & Research Company's 13F filing for Q4 2018, filed 8 Feb 2019.